TDO2-overexpressed Dendritic Cells Possess Tolerogenicity and Ameliorate Collagen-induced Arthritis by Modulating the Th17/Regulatory T Cell Balance
The Journal of Immunology · 15.03.2024 · 212 (6) · 941-950
DOI: 10.4049/jimmunol.2300442 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 31.01.2024. Verfasst von Chengyan Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Tolerogenic dendritic cells are promising for restoring immune homeostasis and may be an alternative therapy for autoimmune diseases such as rheumatoid arthritis. The kynurenine pathway is a vital mechanism that induces tolerance in dendritic cells (DCs). Tryptophan 2,3-dioxygenase (TDO2) is an important rate-limiting enzyme in the kynurenine pathway and participates in immune regulation. However, the role of TDO2 in shaping the tolerogenic phenotypes of DCs remains unclear. In this study, we investigated the effects and mechanisms of TDO2-overexpressed DCs in regulating the T cell balance both in vivo and in vitro. TDO2-overexpressed DC2.4 and TDO2−/− mouse bone marrow–derived DCs (BMDCs) were generated to verify the role of TDO2 in DC maturation and functionality. TDO2 overexpression in BMDCs via PGE2 treatment exhibited an immature phenotype and tolerogenic state, whereas TDO2−/− BMDCs exhibited a mature phenotype and a proinflammatory state. Furthermore, transplant of TDO2-overexpressed BMDCs alleviated collagen-induced arthritis severity in mice, which was correlated with a reduction in Th17 populations and an increase in regulatory T cells. Collectively, these results indicate that TDO2 plays an important role in the tolerogenic phenotype and may be a promising target for the generation tolerogenic DCs for rheumatoid arthritis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Ministry of Educatio…
- Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
ORCID-Profile: Wei Wei, Yingjie Zhao, Yan Chang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of Anhui Province
Zitieren
APA
Jia, C., Wang, Y., Wang, Y., Cheng, M., Dong, W., Wei, W., Zhao, Y., & Chang, Y. (2024). TDO2-overexpressed Dendritic Cells Possess Tolerogenicity and Ameliorate Collagen-induced Arthritis by Modulating the Th17/Regulatory T Cell Balance. The Journal of Immunology, 212(6), 941-950. https://doi.org/10.4049/jimmunol.2300442
Vancouver
Jia C, Wang Y, Wang Y, Cheng M, Dong W, Wei W, et al. TDO2-overexpressed Dendritic Cells Possess Tolerogenicity and Ameliorate Collagen-induced Arthritis by Modulating the Th17/Regulatory T Cell Balance. The Journal of Immunology. 2024;212(6):941-950. doi:10.4049/jimmunol.2300442
BibTeX
@article{Jia2024,
author = {Jia, Chengyan and Wang, Yueye and Wang, Yi and Cheng, Meng and Dong, Weibo and Wei, Wei and Zhao, Yingjie and Chang, Yan},
title = {TDO2-overexpressed Dendritic Cells Possess Tolerogenicity and Ameliorate Collagen-induced Arthritis by Modulating the Th17/Regulatory T Cell Balance},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {6},
pages = {941--950},
doi = {10.4049/jimmunol.2300442}
}
EUVIMED